Latest news from Montefiore Einstein Comprehensive Cancer Center on News en-us Copyright 2024 News 115 31 / /images/newswise-logo-rss.gif /articles/montefiore-einstein-s-marina-konopleva-joins-break-through-cancer-teamlab-in-fight-against-acute-myelogenous-leukemia/?sc=rsin /articles/montefiore-einstein-s-marina-konopleva-joins-break-through-cancer-teamlab-in-fight-against-acute-myelogenous-leukemia/?sc=rsin Tue, 12 Nov 2024 09:00:49 EST Marina Konopleva, M.D., Ph.D., director of the Leukemia Program and co-director of the Blood Cancer Institute at the National Cancer Institute-designated Montefiore Einstein Comprehensive Cancer Center (MECCC), has joined forces with Break Through Cancer, a collaborative medical research foundation that supports teams of scientists as they advance treatments for some of the world's deadliest cancers. Dr. Konopleva will play a pivotal role in the Eradicating Minimal Residual Disease (MRD) in Acute Myelogenous Leukemia (AML) TeamLab. Montefiore Einstein Comprehensive Cancer Center /articles/scientists-discover-that-special-immune-cells-stop-metastatic-cancer/?sc=rsin /articles/scientists-discover-that-special-immune-cells-stop-metastatic-cancer/?sc=rsin Mon, 07 Oct 2024 11:00:00 EST A research team at the National Cancer Institute-designated Montefiore Einstein Comprehensive Cancer Center (MECCC) has discovered a natural immune mechanism in mice that stops escaped cancer cells from developing into tumors elsewhere in the body. The findings were published today in the journal Cell. Montefiore Einstein Comprehensive Cancer Center /articles/montefiore-einstein-comprehensive-cancer-center-establishes-new-immunotherapy-institute/?sc=rsin /articles/montefiore-einstein-comprehensive-cancer-center-establishes-new-immunotherapy-institute/?sc=rsin Mon, 16 Sep 2024 09:05:13 EST The National Cancer Institute-designated Montefiore Einstein Comprehensive Cancer Center (MECCC) has announced the new Marilyn and Stanley M. Katz Institute for Immunotherapy for Cancer and Inflammatory Disorders. Xingxing Zang, Ph.D., an international leader in developing novel immunotherapies, has been named its inaugural director. Montefiore Einstein Comprehensive Cancer Center /articles/montefiore-einstein-comprehensive-cancer-center-awarded-fda-grant-for-clinical-trial-on-experimental-amlmds-treatment/?sc=rsin /articles/montefiore-einstein-comprehensive-cancer-center-awarded-fda-grant-for-clinical-trial-on-experimental-amlmds-treatment/?sc=rsin Tue, 28 Nov 2023 10:00:21 EST Acute myeloid leukemia (AML) and myelodysplastic syndromes (MDS)--two related blood diseases that disproportionally strike older adults--are notoriously difficult to treat and associated with high relapse rates. Montefiore Einstein Comprehensive Cancer Center /articles/montefiore-einstein-comprehensive-cancer-center-awarded-comprehensive-designation-from-the-national-cancer-institute/?sc=rsin /articles/montefiore-einstein-comprehensive-cancer-center-awarded-comprehensive-designation-from-the-national-cancer-institute/?sc=rsin Tue, 12 Sep 2023 12:00:51 EST The newly renamed Montefiore Einstein Comprehensive Cancer Center (MECCC) has been awarded comprehensive designation by the National Cancer Institute (NCI) of the National Institutes of Health, the ultimate standard achieved by only 55 other NCI cancer centers in the U.S. Montefiore Einstein Comprehensive Cancer Center